Skip to Content

C3 (Rubraca 300 mg)

Generic Name: rucaparib

Pill with imprint C3 is Yellow, Elliptical / Oval and has been identified as Rubraca 300 mg. It is supplied by Clovis Oncology, Inc..

Rubraca is used in the treatment of ovarian cancer and belongs to the drug class PARP inhibitors. Rubraca 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C3

Rubraca

Generic Name:
rucaparib
Imprint:
C3
Strength:
300 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
PARP inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Clovis Oncology, Inc.
National Drug Code (NDC):
69660-0203

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide